The full content of Annals is available to subscribers

Subscribe/Learn More  >
Original Research |

Discontinuation of Chemoprophylaxis against Pneumocystis carinii Pneumonia in Patients with HIV Infection

Bienvenido G. Yangco, MD, MPH; Jennifer C. Von Bargen, BS; Anne C. Moorman, BSN, MPH; Scott D. Holmberg, MD, MPH, HIV Outpatient Study (HOPS) Investigators*
[+] Article, Author, and Disclosure Information

From the Infectious Disease Research Institute, Tampa, Florida; and Centers for Disease Control and Prevention, Atlanta, Georgia.

Acknowledgments: The authors thank Kathy Wood, APACHE Medical Systems, Inc., for continued technical support of this project and Jon Kaplan and Alan Greenberg of the Centers for Disease Control and Prevention for helpful advice and editorial suggestions.

Grant Support: By a Cooperative Agreement (U64/CCU5096889) between the Centers for Disease Control and Prevention and the Health Research Network of APACHE Medical Systems.

Requests for Single Reprints: Bienvenido G. Yangco, MD, MPH, 4728 North Habana Avenue, Suite 303, Tampa, FL 33614.

Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints@mail.acponline.org.

Current Author Addresses: Dr. Yangco: 4728 North Habana Avenue, Suite 303, Tampa, FL 33614.

Ms. Moorman, Ms. Von Bargen, and Dr. Holmberg: CDC/DHAP, Mailstop E-45, Atlanta, GA 30333.

Author Contributions: Conception and design: B.G. Yangco, A.C. Moorman, S.D. Holmberg.

Analysis and interpretation of the data: J.C. Von Bargen, A.C. Moorman, S.D. Holmberg.

Drafting of the article: B.G. Yangco, S.D. Holmberg.

Critical revision of the article for important intellectual content: J.C. Von Bargen, S.D. Holmberg.

Final approval of the article: S.D. Holmberg.

Provision of study materials or patients: B.G. Yangco.

Statistical expertise: J.C. Von Bargen.

Obtaining of funding: S.D. Holmberg.

Administrative, technical, or logistic support: A.C. Moorman, S.D. Holmberg.

Collection and assembly of data: B.G. Yangco, A.C. Moorman.

Ann Intern Med. 2000;132(3):201-205. doi:10.7326/0003-4819-132-3-200002010-00005
Text Size: A A A

Background: HIV-infected patients with sustained immunologic improvement from antiretroviral therapy may be able to discontinue chemoprophylaxis against Pneumocystis carinii pneumonia (PCP).

Objective: To compare PCP incidence in HIV-infected patients who had sustained CD4+ lymphocyte counts greater than 200 cells/mm3 and who either discontinued or continued PCP prophylaxis.

Design: Nonrandomized prospective cohort study.

Setting: 10 HIV clinics in eight U.S. cities.

Patients: 146 patients had follow-up visits for a mean of 18.2 months after discontinuation of PCP prophylaxis, and 345 patients who continued PCP prophylaxis had follow-up visits for a mean of 14.0 months.

Measurements: Incidence of PCP.

Results: Patients who discontinued PCP prophylaxis had higher maximum and minimum CD4+ cell counts and lower viral loads than patients who continued PCP prophylaxis. Pneumocystis carinii pneumonia did not develop in either group (upper 95% exact binomial confidence limit of incidence for those who discontinued PCP prophylaxis, 2.3/100 person-years).

Conclusions: Discontinuation of PCP chemoprophylaxis may be appropriate for some HIV-infected ambulatory patients.

*For members of the HIV Outpatient Study Investigators, see Appendix.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Discontinuing Medications Used To Prevent Pneumocystis carinii Pneumonia in Patients with HIV Infection

The summary below is from the full report titled “Discontinuation of Chemoprophylaxis against Pneumocystis carinii Pneumonia in Patients with HIV Infection.” It is in the 1 February 1999 issue of Annals of Internal Medicine (volume 132, pages 201-205). The authors are B.G. Yangco, J.C. Von Bargen, A.C. Moorman, and S.D. Holmberg, for the HIV Outpatient Study (HOPS) Investigator.


Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.